We found that NRF2 and HO-1 protein levels were dramatically suppressed in the EAP group and significantly elevated in the DFO or EDA group, indicating the curative effects of DFO and EDA on prostatitis were likely to mediated by activating NRF2/HO-1 signaling (Figure 8). The gene discussed is NFE2L2; the disease is medical procedure.